Episode 603: Who's eligible for GLP1 in Australia? episode artwork

EPISODE · Aug 17, 2026 · 17 MIN

Episode 603: Who's eligible for GLP1 in Australia?

from The Medical Journal of Australia · host theMJA

My name is Sally Block, the MJA’s news and online editor. “The MJA acknowledges the Traditional Owners and Custodians of the land on which we live and work across Australia.  This podcast was recorded on the lands of the Wangal people. I pay my respects to their Elders past and present.” With the proliferation of GLP 1s globally, a new study published in the MJA aims to provide an estimate of the number of adults eligible for TGA approved medicine for chronic weight management. At least four in ten adults are eligible for the drug and hundreds of thousands are eligible for the treatment of secondary prevention of heart disease. Co-author and PhD candidate Jasmin Castrillon joins me now.

Episode metadata supplied by the publisher feed · Published Aug 17, 2026

Embed this episode

NOW PLAYING

Episode 603: Who's eligible for GLP1 in Australia?

0:00 17:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Medical Journal of Australia?

This episode is 17 minutes long.

When was this The Medical Journal of Australia episode published?

This episode was published on August 17, 2026.

Can I download this The Medical Journal of Australia episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!